{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:11:42Z","timestamp":1782990702432,"version":"3.54.5"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Several studies have evaluated the long-term clinical outcomes of periprocedural myocardial injury for chronic total occlusions patients. However, the results of these studies were inconsistent. To determine whether the periprocedural myocardial injury has adverse effects on long-term clinical outcomes in chronic total occlusion patients undergoing percutaneous coronary intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>We searched Cochrane Library, PubMed, and Embase for eligible articles from their date of inception up to March 2019. Long-term clinical outcomes included major adverse cardiac events, all-cause death, cardiac death, myocardial infarction, and target vessel revascularization. Odds ratios with 95% confidence intervals were calculated as summary statistics by using Review Manager software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>A total of 8 observational studies involving 5879 chronic total occlusions patients were included in this meta-analysis. These results of this meta-analysis indicated that periprocedural myocardial injury was associated with a higher risk of major adverse cardiac events (odds ratio, 1.94; 95% confidence interval, 1.22\u20133.08;<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.005), a higher risk of all-cause death (odds ratio, 1.30; 95% confidence interval, 1.02\u20131.64;<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.03), a higher risk of cardiac death (odds ratio, 2.59; 95% confidence interval, 1.41\u20134.78;<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.002), a higher risk of myocardial infarction (odds ratio, 3.07; 95% confidence interval, 1.90\u20134.98;<jats:italic toggle=\"yes\">P<\/jats:italic>&lt; 0.00001), and a higher risk of target vessel revascularization (odds ratio, 2.07; 95% confidence interval, 1.35\u20133.16;<jats:italic toggle=\"yes\">P<\/jats:italic>=0.0008) than non-periprocedural myocardial injury.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Periprocedural myocardial injury was associated with significantly increased risk of major adverse cardiac events, all-cause death, cardiac death, myocardial infarction, and target vessel revascularization in chronic total occlusion patients undergoing percutaneous coronary intervention at long-term follow-up.<\/jats:p><\/jats:sec>","DOI":"10.1097\/mca.0000000000000813","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T20:26:41Z","timestamp":1573244801000},"page":"208-214","source":"Crossref","is-referenced-by-count":8,"title":["Impact of periprocedural myocardial injury on long-term clinical outcomes of chronic total occlusion patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis"],"prefix":"10.1097","volume":"31","author":[{"given":"Mei-Jun","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Feng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fei","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zhou","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230924","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ccd.25359","article-title":"Temporal trends of fluoroscopy time and contrast utilization in coronary chronic total occlusion revascularization: insights from a multicenter united states registry.","volume":"85","author":"Michael","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"R2-20230924","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcin.2012.10.011","article-title":"Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies.","volume":"6","author":"Patel","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R3-20230924","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jcin.2012.01.012","article-title":"Successful recanalization of chronic total occlusions is associated with improved long-term survival.","volume":"5","author":"Jones","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"R4-20230924","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ccd.24863","article-title":"Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: a meta-analysis comparing successful versus failed percutaneous intervention for chronic total occlusion.","volume":"82","author":"Khan","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"R5-20230924","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ccd.23019","article-title":"Long-term clinical outcomes of successful versus unsuccessful revascularization with drug-eluting stents for true chronic total occlusion.","volume":"78","author":"Lee","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"R6-20230924","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ccd.21092","article-title":"Percutaneous coronary intervention for chronic total occlusions: improved survival for patients with successful revascularization compared to a failed procedure.","volume":"70","author":"Aziz","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"R7-20230924","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCINTERVENTIONS.108.765610","article-title":"Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.","volume":"1","author":"Prasad","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"key":"R8-20230924","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/eurheartj\/ehi173","article-title":"Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.","volume":"26","author":"Cavallini","year":"2005","journal-title":"Eur Heart J"},{"key":"R9-20230924","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0735-1097(03)01044-1","article-title":"Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention.","volume":"42","author":"Ioannidis","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R10-20230924","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ehj.2003.12.009","article-title":"Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.","volume":"25","author":"Roe","year":"2004","journal-title":"Eur Heart J"},{"key":"R11-20230924","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0735-1097(98)00551-8","article-title":"Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II investigators. Integrilin (eptifibatide) to minimize platelet aggregation and coronary thrombosis-II.","volume":"33","author":"Tardiff","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R12-20230924","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJMra0912134","article-title":"Myocardial infarction due to percutaneous coronary intervention.","volume":"364","author":"Prasad","year":"2011","journal-title":"N Engl J Med"},{"key":"R13-20230924","doi-asserted-by":"crossref","first-page":"E308","DOI":"10.1002\/ccd.27545","article-title":"Incidence, predictors and longer-term impact of troponin elevation following hybrid chronic total occlusion percutaneous coronary intervention.","volume":"92","author":"Dautov","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"R14-20230924","first-page":"410","article-title":"Periprocedural myocardial injury and long-term clinical outcome in patients undergoing percutaneous coronary interventions of coronary chronic total occlusion.","volume":"28","author":"Di Serafino","year":"2016","journal-title":"J Invasive Cardiol"},{"key":"R15-20230924","first-page":"63","article-title":"Periprocedural myocardial injury after recanalization of single chronic coronary occlusion: a propensity score analysis comparing long-term clinical outcomes.","volume":"29","author":"Jaguszewski","year":"2017","journal-title":"J Invasive Cardiol"},{"key":"R16-20230924","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ccd.26286","article-title":"Association of periprocedural myocardial infarction with long-term survival in patients treated with coronary revascularization therapy of chronic total occlusion.","volume":"87","author":"Jang","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"R17-20230924","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ccd.27420","article-title":"Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.","volume":"92","author":"Kim","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"R18-20230924","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4244\/EIJ-D-17-00338","article-title":"Clinical implications of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention for chronic total occlusion: role of antegrade and retrograde crossing techniques.","volume":"13","author":"Toma","year":"2018","journal-title":"Eurointervention"},{"issue":"Suppl 1","key":"R19-20230924","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ccd.26406","article-title":"Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: results from a prospective, single center PCI registry.","volume":"87","author":"Zhang","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"R20-20230924","doi-asserted-by":"crossref","first-page":"B57","DOI":"10.1093\/eurheartj\/suv022","article-title":"Clinical outcomes and risk factors of periprocedural myocardial injury after successful percutaneous coronary intervention for chronic total occlusions.","volume":"17","author":"Zhong","year":"2015","journal-title":"Eur Heart J"},{"key":"R21-20230924","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/eurheartj\/eht048","article-title":"Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention.","volume":"34","author":"Park","year":"2013","journal-title":"Eur Heart J"},{"key":"R22-20230924","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2006.04.102","article-title":"Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality.","volume":"48","author":"Prasad","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R23-20230924","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/ccd.22962","article-title":"Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis.","volume":"77","author":"Feldman","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"R24-20230924","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.jcin.2016.08.005","article-title":"Determinants and prognostic significance of periprocedural myocardial injury in patients with successful percutaneous chronic total occlusion interventions.","volume":"9","author":"Lee","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R25-20230924","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcin.2013.07.011","article-title":"Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study.","volume":"7","author":"Lo","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"R26-20230924","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/hc3101.093902","article-title":"Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients.","volume":"104","author":"Stone","year":"2001","journal-title":"Circulation"},{"key":"R27-20230924","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCULATIONAHA.105.593210","article-title":"Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound.","volume":"114","author":"Porto","year":"2006","journal-title":"Circulation"},{"key":"R28-20230924","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/01.CIR.68.5.986","article-title":"Fifteen year survival study of patients with obstructive coronary artery disease.","volume":"68","author":"Proudfit","year":"1983","journal-title":"Circulation"},{"key":"R29-20230924","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0002-9149(00)01039-0","article-title":"Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention.","volume":"86","author":"Kanaparti","year":"2000","journal-title":"Am J Cardiol"},{"key":"R30-20230924","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.CIR.101.6.604","article-title":"Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients.","volume":"101","author":"Mehran","year":"2000","journal-title":"Circulation"},{"key":"R31-20230924","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0002-9149(02)02253-1","article-title":"Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention.","volume":"89","author":"Saadeddin","year":"2002","journal-title":"Am J Cardiol"},{"key":"R32-20230924","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.CIR.0000137828.06205.87","article-title":"Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (atorvastatin for reduction of myocardial damage during angioplasty) study.","volume":"110","author":"Pasceri","year":"2004","journal-title":"Circulation"},{"key":"R33-20230924","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade.","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"R34-20230924","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jacc.2003.12.034","article-title":"Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.","volume":"43","author":"Chen","year":"2004","journal-title":"J Am Coll Cardiol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T15:55:58Z","timestamp":1722009358000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000813","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}